You, Hua-Jing
Fang, Shu-Bin
Wu, Teng-Teng
Zhang, Hongyu
Feng, Yu-Kun
Li, Xue-Jiao
Yang, Hui-Hua
Li, Ge
Li, Xun-Hua
Wu, Chao
Fu, Qing-Ling
Pei, Zhong
Funding for this research was provided by:
National Natural Science Foundation of China (81873751, 81671102)
The National Key Research and Development Program of China, Stem Cell and Translational Research (2017YFA0105104)
Guangdong provincial science and technology plan project (2016B030230002, 2017A040406007)
Guangdong Provincial Key Laboratory for Diagnosis and Treatment of Major Neurological Diseases (2017B030314103)
The Southern China International Cooperation Base for Early Intervention and Functional Rehabilitation of Neurological Diseases (2015B050501003)
Guangdong Provincial Engineering Center for Major Neurological Disease Treatment (Not Applicable)
Guangdong Provincial Translational Medicine Innovation Platform for Diagnosis and Treatment of Major Neurological Disease (Not applicable)
Article History
Received: 13 October 2019
Revised: 19 April 2020
Accepted: 12 May 2020
First Online: 8 June 2020
Ethics approval and consent to participate
: This study was approved by the Ethics Committee of The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China. All experimental procedures were in accordance with the guidelines of the Animal Research Committee of The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China, for the use and care of laboratory animals.
: Not applicable.
: The authors declare that they have no competing interests.